Cargando…
Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Hematology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631665/ https://www.ncbi.nlm.nih.gov/pubmed/35687492 http://dx.doi.org/10.1182/bloodadvances.2021006193 |
| _version_ | 1784823863531536384 |
|---|---|
| author | Jaeger, Ulrich Tam, Constantine S. Borchmann, Peter McGuirk, Joseph P. Johansen, Marianne Waller, Edmund K. Jaglowski, Samantha Andreadis, Charalambos Foley, Stephen R. Westin, Jason R. Fleury, Isabelle Ho, P. Joy Mielke, Stephan Teshima, Takanori Salles, Gilles Schuster, Stephen J. He, Fiona Maziarz, Richard T. Mayer, Sebastian Makita, Shinichi Kersten, Marie J. Ghosh, Monalisa Wagner-Johnston, Nina Kato, Koji Corradini, Paolo Goto, Hideki Colicino, Silvia Agarwal, Abhijit Lobetti-Bodoni, Chiara Bishop, Michael R. |
| author_facet | Jaeger, Ulrich Tam, Constantine S. Borchmann, Peter McGuirk, Joseph P. Johansen, Marianne Waller, Edmund K. Jaglowski, Samantha Andreadis, Charalambos Foley, Stephen R. Westin, Jason R. Fleury, Isabelle Ho, P. Joy Mielke, Stephan Teshima, Takanori Salles, Gilles Schuster, Stephen J. He, Fiona Maziarz, Richard T. Mayer, Sebastian Makita, Shinichi Kersten, Marie J. Ghosh, Monalisa Wagner-Johnston, Nina Kato, Koji Corradini, Paolo Goto, Hideki Colicino, Silvia Agarwal, Abhijit Lobetti-Bodoni, Chiara Bishop, Michael R. |
| author_sort | Jaeger, Ulrich |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9631665 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American Society of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96316652022-11-04 Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma Jaeger, Ulrich Tam, Constantine S. Borchmann, Peter McGuirk, Joseph P. Johansen, Marianne Waller, Edmund K. Jaglowski, Samantha Andreadis, Charalambos Foley, Stephen R. Westin, Jason R. Fleury, Isabelle Ho, P. Joy Mielke, Stephan Teshima, Takanori Salles, Gilles Schuster, Stephen J. He, Fiona Maziarz, Richard T. Mayer, Sebastian Makita, Shinichi Kersten, Marie J. Ghosh, Monalisa Wagner-Johnston, Nina Kato, Koji Corradini, Paolo Goto, Hideki Colicino, Silvia Agarwal, Abhijit Lobetti-Bodoni, Chiara Bishop, Michael R. Blood Adv Commentary American Society of Hematology 2022-08-18 /pmc/articles/PMC9631665/ /pubmed/35687492 http://dx.doi.org/10.1182/bloodadvances.2021006193 Text en © 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. |
| spellingShingle | Commentary Jaeger, Ulrich Tam, Constantine S. Borchmann, Peter McGuirk, Joseph P. Johansen, Marianne Waller, Edmund K. Jaglowski, Samantha Andreadis, Charalambos Foley, Stephen R. Westin, Jason R. Fleury, Isabelle Ho, P. Joy Mielke, Stephan Teshima, Takanori Salles, Gilles Schuster, Stephen J. He, Fiona Maziarz, Richard T. Mayer, Sebastian Makita, Shinichi Kersten, Marie J. Ghosh, Monalisa Wagner-Johnston, Nina Kato, Koji Corradini, Paolo Goto, Hideki Colicino, Silvia Agarwal, Abhijit Lobetti-Bodoni, Chiara Bishop, Michael R. Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma |
| title | Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma |
| title_full | Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma |
| title_fullStr | Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma |
| title_full_unstemmed | Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma |
| title_short | Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma |
| title_sort | long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large b-cell lymphoma |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631665/ https://www.ncbi.nlm.nih.gov/pubmed/35687492 http://dx.doi.org/10.1182/bloodadvances.2021006193 |
| work_keys_str_mv | AT jaegerulrich longtermsafetyforpatientswithtisagenlecleuceltreatedrelapsedrefractorydiffuselargebcelllymphoma AT tamconstantines longtermsafetyforpatientswithtisagenlecleuceltreatedrelapsedrefractorydiffuselargebcelllymphoma AT borchmannpeter longtermsafetyforpatientswithtisagenlecleuceltreatedrelapsedrefractorydiffuselargebcelllymphoma AT mcguirkjosephp longtermsafetyforpatientswithtisagenlecleuceltreatedrelapsedrefractorydiffuselargebcelllymphoma AT johansenmarianne longtermsafetyforpatientswithtisagenlecleuceltreatedrelapsedrefractorydiffuselargebcelllymphoma AT walleredmundk longtermsafetyforpatientswithtisagenlecleuceltreatedrelapsedrefractorydiffuselargebcelllymphoma AT jaglowskisamantha longtermsafetyforpatientswithtisagenlecleuceltreatedrelapsedrefractorydiffuselargebcelllymphoma AT andreadischaralambos longtermsafetyforpatientswithtisagenlecleuceltreatedrelapsedrefractorydiffuselargebcelllymphoma AT foleystephenr longtermsafetyforpatientswithtisagenlecleuceltreatedrelapsedrefractorydiffuselargebcelllymphoma AT westinjasonr longtermsafetyforpatientswithtisagenlecleuceltreatedrelapsedrefractorydiffuselargebcelllymphoma AT fleuryisabelle longtermsafetyforpatientswithtisagenlecleuceltreatedrelapsedrefractorydiffuselargebcelllymphoma AT hopjoy longtermsafetyforpatientswithtisagenlecleuceltreatedrelapsedrefractorydiffuselargebcelllymphoma AT mielkestephan longtermsafetyforpatientswithtisagenlecleuceltreatedrelapsedrefractorydiffuselargebcelllymphoma AT teshimatakanori longtermsafetyforpatientswithtisagenlecleuceltreatedrelapsedrefractorydiffuselargebcelllymphoma AT sallesgilles longtermsafetyforpatientswithtisagenlecleuceltreatedrelapsedrefractorydiffuselargebcelllymphoma AT schusterstephenj longtermsafetyforpatientswithtisagenlecleuceltreatedrelapsedrefractorydiffuselargebcelllymphoma AT hefiona longtermsafetyforpatientswithtisagenlecleuceltreatedrelapsedrefractorydiffuselargebcelllymphoma AT maziarzrichardt longtermsafetyforpatientswithtisagenlecleuceltreatedrelapsedrefractorydiffuselargebcelllymphoma AT mayersebastian longtermsafetyforpatientswithtisagenlecleuceltreatedrelapsedrefractorydiffuselargebcelllymphoma AT makitashinichi longtermsafetyforpatientswithtisagenlecleuceltreatedrelapsedrefractorydiffuselargebcelllymphoma AT kerstenmariej longtermsafetyforpatientswithtisagenlecleuceltreatedrelapsedrefractorydiffuselargebcelllymphoma AT ghoshmonalisa longtermsafetyforpatientswithtisagenlecleuceltreatedrelapsedrefractorydiffuselargebcelllymphoma AT wagnerjohnstonnina longtermsafetyforpatientswithtisagenlecleuceltreatedrelapsedrefractorydiffuselargebcelllymphoma AT katokoji longtermsafetyforpatientswithtisagenlecleuceltreatedrelapsedrefractorydiffuselargebcelllymphoma AT corradinipaolo longtermsafetyforpatientswithtisagenlecleuceltreatedrelapsedrefractorydiffuselargebcelllymphoma AT gotohideki longtermsafetyforpatientswithtisagenlecleuceltreatedrelapsedrefractorydiffuselargebcelllymphoma AT colicinosilvia longtermsafetyforpatientswithtisagenlecleuceltreatedrelapsedrefractorydiffuselargebcelllymphoma AT agarwalabhijit longtermsafetyforpatientswithtisagenlecleuceltreatedrelapsedrefractorydiffuselargebcelllymphoma AT lobettibodonichiara longtermsafetyforpatientswithtisagenlecleuceltreatedrelapsedrefractorydiffuselargebcelllymphoma AT bishopmichaelr longtermsafetyforpatientswithtisagenlecleuceltreatedrelapsedrefractorydiffuselargebcelllymphoma |